| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥418.7B | ¥412.4B | +1.5% |
| Operating Income | ¥14.6B | ¥29.0B | -49.9% |
| Ordinary Income | ¥19.2B | ¥33.5B | -42.5% |
| Net Income | ¥12.7B | ¥21.6B | -41.1% |
| ROE | 2.1% | 3.6% | - |
FY2026 Q3 consolidated results show TEIKA Corporation reporting revenue of 418.7 billion yen (YoY +1.5%), operating income of 14.6 billion yen (YoY -49.9%), ordinary income of 19.2 billion yen (YoY -42.5%), and net income of 12.7 billion yen (YoY -41.1%). The company faced significant profit compression despite maintaining revenue stability, with operating margin declining to approximately 3.5% from 7.0% in the prior year period. The gap between operating income and ordinary income reflects substantial support from non-operating income, particularly dividend income of 4.69 billion yen. Total assets expanded to 912.9 billion yen from 883.5 billion yen, while equity strengthened to 617.0 billion yen from 594.0 billion yen, maintaining a solid capital base despite operational challenges.
Revenue increased modestly by 1.5% to 418.7 billion yen, driven by segment performance showing contrasting trends between business units. The Electronic Material and Basic Chemical segment generated sales of 21.2 billion yen (prior year 18.6 billion yen, +14.1%), while the Functional Chemical segment contracted to 19.8 billion yen (prior year 21.8 billion yen, -9.3%). The overall revenue growth was constrained by the declining performance in Functional Chemicals, which previously represented the larger business segment.
Operating income declined sharply by 49.9% to 14.6 billion yen from 29.0 billion yen, reflecting a compression in gross margin to 15.4% and elevated operating expense burden. The primary profit deterioration stems from cost structure pressures and segment-level profitability issues. Selling, general and administrative expenses of 49.9 billion yen remained relatively stable year-over-year but absorbed a substantially larger proportion of gross profit due to the margin decline.
Ordinary income of 19.2 billion yen includes non-operating income of 5.89 billion yen, predominantly comprising dividend income of 4.69 billion yen, which provided critical support to bottom-line results. The 4.6 billion yen contribution from dividends represents approximately 1.1% of revenue, indicating material reliance on financial income to offset operational weakness. Net income of 12.7 billion yen reflects a tax burden with an effective tax rate of approximately 29.9%, calculated from the ordinary-to-net income progression.
Non-recurring factors were not explicitly disclosed in impairment information, with no material asset impairment losses or restructuring charges reported during the period. The earnings decline appears attributable to fundamental business performance deterioration rather than extraordinary items.
This represents a revenue up/profit down pattern, where modest top-line growth failed to translate into proportional profit expansion due to margin compression and unfavorable business mix shifts.
The Functional Chemical segment reported revenue of 19.8 billion yen with an operating loss of 603 million yen, representing a significant deterioration from the prior year operating profit of 1.3 billion yen. This segment shifted from profitability to loss-making status, with an operating margin of negative 3.0%, indicating fundamental profitability challenges requiring structural intervention.
The Electronic Material and Basic Chemical segment generated revenue of 21.2 billion yen with operating income of 1.9 billion yen, yielding an operating margin of 8.8%. While this segment demonstrated resilience with revenue growth of 14.1% year-over-year, the operating profit increased by 30.1% from 1.4 billion yen, suggesting improved operational leverage despite the challenging overall environment.
The Electronic Material and Basic Chemical segment emerges as the core profitable business, representing 51.8% of total segment revenue and generating all positive operating profits. The sharp contrast in profitability between segments, with a margin differential exceeding 11 percentage points, highlights significant portfolio imbalance and concentration risk in operational performance.
[Profitability] ROE of 2.0% declined significantly from prior year levels, reflecting compressed earnings relative to equity base. Operating margin of 3.5% represents substantial deterioration from 7.0% in the prior year period, declining 3.5 percentage points year-over-year. Net profit margin of 3.0% compares to the prior period margin compression, driven by both operating leverage deterioration and reliance on non-operating dividend income to support bottom-line results. [Cash Quality] Cash and equivalents of 93.96 billion yen provide 2.0 times coverage of short-term debt of 46.91 billion yen, maintaining adequate near-term liquidity cushion despite cash declining 33.3% from prior year level of 140.92 billion yen. [Investment Efficiency] Asset turnover of 0.459 indicates moderate asset utilization efficiency, with total assets of 912.9 billion yen supporting annualized revenue generation. ROIC of 1.6% reflects substantial underperformance relative to capital cost expectations, signaling meaningful capital efficiency concerns requiring operational intervention. [Financial Health] Equity ratio of 67.6% demonstrates strong capital adequacy, substantially exceeding typical leverage thresholds. Current ratio of 282.5% reflects robust short-term liquidity positioning. Debt-to-equity ratio of 0.19 indicates conservative financial leverage with interest-bearing debt of 117.3 billion yen relative to equity of 617.0 billion yen, maintaining financial flexibility despite operational pressures.
Cash and deposits decreased 46.96 billion yen year-over-year to 93.96 billion yen, representing a 33.3% decline that reflects material cash outflows during the period. This substantial liquidity reduction occurred despite maintaining profitability, suggesting significant working capital absorption or investment activity. Notes and accounts receivable increased to 181.5 billion yen from 173.4 billion yen, absorbing 8.1 billion yen of operating cash flow through extended customer credit or revenue timing effects. Inventory expanded to 94.81 billion yen from 91.58 billion yen, representing 3.2 billion yen of additional working capital deployment, potentially reflecting production planning adjustments or demand softness. Accounts payable increased 17.77 billion yen to 80.10 billion yen from 62.33 billion yen, providing partial working capital relief through extended supplier payment terms. Investment securities increased substantially by 33.19 billion yen to 155.54 billion yen from 122.35 billion yen, representing a material cash deployment into financial assets that explains a significant portion of the cash balance reduction. The combination of working capital expansion and increased investment securities holdings consumed operating cash generation, resulting in the 46.96 billion yen cash decline. Short-term liquidity coverage remains adequate at 2.0 times short-term debt, though the reduced cash buffer warrants continued monitoring given ongoing working capital demands.
Ordinary income of 19.2 billion yen versus operating income of 14.6 billion yen indicates a positive non-operating contribution of approximately 4.6 billion yen, representing 31.5% of operating income. This substantial non-operating support comprises primarily dividend income of 4.69 billion yen, with additional financial income and minor equity method contributions. Non-operating income represents 1.4% of revenue, consisting predominantly of investment returns on the 155.54 billion yen securities portfolio. The dividend income of 4.69 billion yen suggests an approximate 3.0% yield on investment securities, indicating the company derives meaningful earnings contribution from financial asset holdings rather than core operations. The material reliance on non-operating income to bridge operating income to ordinary income levels raises sustainability concerns regarding underlying business earnings power. While cash flow statement data is not available for quarterly reporting, balance sheet analysis reveals working capital deterioration with accounts receivable increasing 4.7% and inventory expanding 3.5% year-over-year, suggesting potential quality concerns regarding earnings conversion to cash. The 33.3% decline in cash balances despite reporting net income of 12.7 billion yen indicates operating cash generation substantially trails reported earnings, primarily due to working capital expansion and investment securities accumulation of 33.19 billion yen during the period.
Full-year guidance projects revenue of 580.0 billion yen, operating income of 17.0 billion yen, ordinary income of 21.0 billion yen, and net income of 13.0 billion yen. At Q3 completion, progress rates stand at 72.2% for revenue, 85.6% for operating income, 91.6% for ordinary income, and 95.7% for net income against full-year targets. Operating income progress of 85.6% significantly exceeds the standard 75% benchmark for Q3, suggesting Q4 will deliver substantially lower sequential profitability of approximately 2.4 billion yen operating income compared to the Q3 run rate. Similarly, net income progress at 95.7% of full-year guidance implies Q4 net income of only 0.56 billion yen, representing material sequential decline from the quarterly average. The company has revised full-year expectations downward with operating income declining 51.8% year-over-year, ordinary income declining 44.0%, and revenue growing modestly by 4.1%. The elevated progress rates and guidance revision reflect weaker-than-anticipated Q1-Q2 performance requiring Q3-Q4 improvement that has only partially materialized. The Q4 implied profitability suggests continued operational challenges, with the company expecting limited recovery in the final quarter despite the Q3 results.
The company paid an interim dividend of 18.0 yen per share and forecasts a year-end dividend of 20.0 yen per share, totaling an annual dividend of 40.0 yen per share. This represents a payout ratio of approximately 73.1% based on full-year net income guidance of 13.0 billion yen and the forecasted dividend per share. The elevated payout ratio reflects management commitment to shareholder returns despite profitability compression, though sustainability warrants evaluation given the substantial decline in operating cash generation indicated by the 33.3% reduction in cash balances. No share buyback activity was disclosed during the period, with total shareholder returns limited to dividend payments. The payout ratio of 73.1% exceeds typical sustainable thresholds of 40-50% for manufacturing companies, particularly concerning given working capital expansion absorbing operating cash flow and the 46.96 billion yen decline in cash reserves. The dividend policy appears dependent on maintaining investment income from the 155.54 billion yen securities portfolio, as core operating cash generation appears insufficient to support the current dividend level alongside working capital and investment requirements.
Functional Chemical segment profitability deterioration represents the most immediate operational risk, with the segment shifting from 1.3 billion yen profit to 603 million yen loss year-over-year. This negative 3.0% operating margin requires urgent structural intervention through cost optimization, product portfolio rationalization, or potential exit considerations. The segment revenue decline of 9.3% combined with margin collapse indicates both volume and profitability pressures requiring comprehensive strategic review.
Working capital efficiency degradation poses material cash generation risk, with accounts receivable expanding to 181.5 billion yen and inventory reaching 94.81 billion yen. Days sales outstanding, inventory holding periods, and overall cash conversion cycle extension absorb operating cash flow and contribute to the 33.3% cash balance decline. Failure to improve collection efficiency and inventory management will further constrain financial flexibility and dividend sustainability.
Dividend policy sustainability presents financial risk given the 73.1% payout ratio dependent on non-operating dividend income rather than operating cash generation. The 4.69 billion yen dividend income from investment securities provides critical support to shareholder distributions, creating vulnerability to securities portfolio valuation changes or issuer dividend policy modifications. Combined with depleting cash reserves declining 46.96 billion yen year-over-year, the current 40.0 yen annual dividend may require reconsideration absent operating performance recovery.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics demonstrate substantial underperformance relative to manufacturing sector medians. ROE of 2.0% significantly trails the industry median of 5.0%, positioning the company in the lower quartile of sector performance. Operating margin of 3.5% falls meaningfully below the industry median of 8.3%, indicating structural cost disadvantages or unfavorable product mix relative to peers. Net profit margin of 3.0% compares unfavorably to the sector median of 6.3%, with the company's margin compression driven by both lower operating margins and elevated tax burden.
Financial health indicators present relative strength despite operational challenges. Equity ratio of 67.6% exceeds the industry median of 63.8%, reflecting conservative capital structure and substantial financial flexibility. Current ratio of 282.5% substantially surpasses the industry median of 2.84 times, indicating robust short-term liquidity positioning despite the recent cash decline. Financial leverage of 1.48 times aligns closely with the industry median of 1.53 times, confirming the company maintains sector-typical capital structure.
Efficiency metrics reveal mixed positioning. Asset turnover of 0.459 falls below the industry median of 0.58, indicating suboptimal asset utilization requiring operational improvement. Revenue growth of 1.5% aligns with the industry median of 2.7%, though this modest differential masks the significant profitability underperformance. ROIC of 1.6% substantially underperforms the sector median of 5.0%, highlighting capital allocation efficiency concerns and return generation challenges requiring strategic intervention.
(Industry: Manufacturing sector, N=98 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Structural profitability recovery requirement emerges as the primary earnings characteristic, with operating margin compression from 7.0% to 3.5% and ROE declining to 2.0% substantially below both historical performance and industry medians. The Functional Chemical segment loss of 603 million yen and gross margin decline to 15.4% necessitate fundamental business model intervention through cost structure optimization, product portfolio repositioning, or strategic alternative evaluation. Operating leverage restoration through the elimination of segment losses could restore 3-4 percentage points to consolidated operating margin, representing the most immediate value creation opportunity.
Financial income dependency presents a distinctive earnings pattern requiring evaluation, with dividend income of 4.69 billion yen representing 24.4% of ordinary income and providing critical support to shareholder distributions. The investment securities portfolio of 155.54 billion yen generates returns partially insulating bottom-line results from operational weakness, though this creates sustainability questions regarding core business earnings power. The portfolio expansion of 33.19 billion yen during the period while cash declined 46.96 billion yen suggests strategic asset allocation toward investment income generation, though this approach reduces resources available for operational improvement or organic growth investment.
Working capital management deterioration emerges as an observable trend affecting cash generation capacity, with receivables expanding 4.7%, inventory increasing 3.5%, and combined working capital absorption contributing materially to the 33.3% cash decline. The elevated 73.1% dividend payout ratio remains dependent on investment income sustainability and requires operating cash flow improvement to ensure long-term viability. Near-term monitoring priorities include Functional Chemical segment restructuring progress, working capital efficiency metrics including days sales outstanding and inventory turnover, and the sustainability of the securities portfolio yield supporting dividend policy.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.